← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

# Name Holding Trade Value Theme
Stocks
% of
Portfolio
Status
126
Marshall Wace North America
Marshall Wace North America
New York
$548M -$1.03M 31 2.65% Reduced
127
Prudential Financial
Prudential Financial
New Jersey
$541M -$158M 28 0.8% Reduced
128
Bank of Montreal
Bank of Montreal
Ontario, Canada
$532M +$28.9M 78 0.4% Increased
129
DF Dent & Co
DF Dent & Co
Maryland
$531M -$17.3M 5 8.98% Reduced
130
Stifel Financial
Stifel Financial
Missouri
$522M +$76.1M 32 1.09% Increased
131
FCMI
Foresite Capital Management II
California
$521M $0 1 85.84% Maintained
132
SEI Investments
SEI Investments
Pennsylvania
$521M +$20.4M 33 1.55% Increased
133
Avoro Capital Advisors
Avoro Capital Advisors
New York
$519M +$55.6M 5 15.24% Increased
134
Marshall Wace
Marshall Wace
United Kingdom
$515M -$98.7M 33 3.54% Reduced
135
Candriam SCA
Candriam SCA
Luxembourg
$504M +$6.16M 22 5.4% Increased
136
EARNEST Partners
EARNEST Partners
Georgia
$503M +$20.2M 16 3.96% Increased
137
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
$498M +$16M 52 1.25% Increased
138
Korea Investment Corp
Korea Investment Corp
South Korea
$496M +$159M 8 1.81% Increased
139
NN Investment Partners Holdings
NN Investment Partners Holdings
Netherlands
$491M +$20.2M 7 3.33% Increased
140
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
$490M -$85.4M 19 1.63% Reduced
141
CC
Casdin Capital
New York
$488M -$1.68M 14 44.86% Reduced
142
HSBC Holdings
HSBC Holdings
United Kingdom
$486M -$8.91M 24 0.84% Reduced
143
Raymond James & Associates
Raymond James & Associates
Florida
$486M +$12.3M 42 0.62% Increased
144
JSP
Jackson Square Partners
California
$479M -$69.5M 1 2.51% Reduced
145
Ninety One (UK)
Ninety One (UK)
United Kingdom
$476M -$17.2M 3 1.58% Reduced
146
ALSV
ATP Life Science Ventures
New York
$475M +$422M 1 79.82% New
147
Panagora Asset Management
Panagora Asset Management
Massachusetts
$466M -$46.2M 38 2.11% Reduced
148
Westfield Capital Management
Westfield Capital Management
Massachusetts
$464M +$114M 10 3.3% Increased
149
Aperio Group
Aperio Group
California
$458M +$3.78M 32 1.64% Increased
150
VOYA Investment Management
VOYA Investment Management
Georgia
$450M -$97.7M 54 0.93% Reduced